McLaughlin M - Search Results

1

Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.

Sharif NA, Xu SX, Crider JY, McLaughlin M, Davis TL. Sharif NA, et al. Among authors: mclaughlin m. J Ocul Pharmacol Ther. 2001 Aug;17(4):305-17. doi: 10.1089/108076801753162726. J Ocul Pharmacol Ther. 2001. PMID: 11572462

2

Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.

Sharif NA, McLaughlin MA, Kelly CR, Xu S, Crider JY, Williams GW, Parker JL. Sharif NA, et al. J Ocul Pharmacol Ther. 2006 Oct;22(5):291-309. doi: 10.1089/jop.2006.22.291. J Ocul Pharmacol Ther. 2006. PMID: 17076623

3

AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist.

Sharif NA, McLaughlin MA, Kelly CR. Sharif NA, et al. J Ocul Pharmacol Ther. 2007 Feb;23(1):1-13. doi: 10.1089/jop.2006.0093. J Ocul Pharmacol Ther. 2007. PMID: 17341144

4

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.

Hellberg MR, Sallee VL, McLaughlin MA, Sharif NA, Desantis L, Dean TR, Zinke PW. Hellberg MR, et al. Among authors: mclaughlin ma. J Ocul Pharmacol Ther. 2001 Oct;17(5):421-32. doi: 10.1089/108076801753266802. J Ocul Pharmacol Ther. 2001. PMID: 11765147

5

Levobetaxolol (Betaxon): in vitro pharmacology, intraocular pressure lowering activity and autoradiographic localization of beta-adrenoceptors in human eyes.

Sharif NA, Crider JY, Xu SX, McLaughlin M, Davis TL. Sharif NA, et al. Among authors: mclaughlin m. Proc West Pharmacol Soc. 2001;44:65-8. Proc West Pharmacol Soc. 2001. PMID: 11793997 No abstract available.

6

Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.

Sharif NA, Kelly CR, McLaughlin M. Sharif NA, et al. Among authors: mclaughlin m. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4001-10. doi: 10.1167/iovs.06-0062. Invest Ophthalmol Vis Sci. 2006. PMID: 16936116

7

3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.

Hellberg MR, Conrow RE, Sharif NA, McLaughlin MA, Bishop JE, Crider JY, Dean WD, DeWolf KA, Pierce DR, Sallee VL, Selliah RD, Severns BS, Sproull SJ, Williams GW, Zinke PW, Klimko PG. Hellberg MR, et al. Bioorg Med Chem. 2002 Jun;10(6):2031-49. doi: 10.1016/s0968-0896(02)00016-0. Bioorg Med Chem. 2002. PMID: 11937363

8

Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys.

May JA, McLaughlin MA, Sharif NA, Hellberg MR, Dean TR. May JA, et al. J Pharmacol Exp Ther. 2003 Jul;306(1):301-9. doi: 10.1124/jpet.103.049528. Epub 2003 Apr 3. J Pharmacol Exp Ther. 2003. PMID: 12676887

9

A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.

May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA. May JA, et al. Among authors: mclaughlin ma. J Med Chem. 2003 Sep 11;46(19):4188-95. doi: 10.1021/jm030205t. J Med Chem. 2003. PMID: 12954071

10

Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.

Feng Z, Mohapatra S, Klimko PG, Hellberg MR, May JA, Kelly C, Williams G, McLaughlin MA, Sharif NA. Feng Z, et al. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2998-3002. doi: 10.1016/j.bmcl.2007.03.073. Epub 2007 Mar 25. Bioorg Med Chem Lett. 2007. PMID: 17419053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,512 results

Search Page